Raymond James & Associates Buys 1,836 Shares of Livent Co. (NYSE:LTHM)

Raymond James & Associates increased its stake in shares of Livent Co. (NYSE:LTHM – Get Rating) by 1.0% in the 4th quarter, Holdings Channel.com reports. The institutional investor owned 193,149 shares of the company’s stock after acquiring an additional 1,836 shares during the period. Raymond James & Associates’ holdings in Livent were worth $3,838,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also modified their holdings of the stock. Navellier & Associates Inc. lifted its position in shares of Livent by 1.4% during the 4th quarter. Navellier & Associates Inc. now owns 29,633 shares of the company’s stock worth $589,000 after buying an additional 404 shares during the period. Vectors Research Management LLC lifted its position in shares of Livent by 4.2% during the 3rd quarter. Vectors Research Management LLC now owns 10,984 shares of the company’s stock worth $337,000 after buying an additional 447 shares during the period. Crossmark Global Holdings Inc. lifted its position in shares of Livent by 3.1% during the 4th quarter. Crossmark Global Holdings Inc. now owns 15,433 shares of the company’s stock worth $306,000 after buying an additional 458 shares during the period. Regent Investment Management LLC lifted its position in shares of Livent by 0.9% during the 4th quarter. Regent Investment Management LLC now owns 58,025 shares of the company’s stock worth $1,153,000 after buying an additional 500 shares during the period. Finally, Great West Life Assurance Co. Can lifted its position in shares of Livent by 0.4% during the 1st quarter. Great West Life Assurance Co. Can now owns 139,532 shares of the company’s stock worth $3,734,000 after buying an additional 529 shares during the period. Institutional investors own 90.62% of the company’s stock.

Livent Stock Down 0.4 %

LTHM stock opened at $24.47 on Thursday. The company has a debt-to-equity ratio of 0.16, a current ratio of 4.23 and a quick ratio of 2.83. The stock has a market capitalization of $4.40 billion, a P/E ratio of 15.11, a P/E/G ratio of 0.40 and a beta of 1.81. The business has a 50-day moving average of $22.23 and a 200-day moving average of $23.75. Livent Co. has a fifty-two week low of $18.26 and a fifty-two week high of $36.38.

Livent (NYSE:LTHM – Get Rating) last released its earnings results on Tuesday, May 2nd. The company reported $0.60 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.39 by $0.21. Livent had a return on equity of 26.15% and a net margin of 36.30%. The business had revenue of $235.50 million for the quarter, compared to analyst estimates of $229.94 million. During the same quarter in the prior year, the company posted $0.21 earnings per share. Livent’s revenue was up 64.1% on a year-over-year basis. On average, sell-side analysts anticipate that Livent Co. will post 2.01 earnings per share for the current fiscal year.

Analyst Ratings Changes

LTHM has been the subject of several research analyst reports. Raymond James cut their price objective on Livent from $35.00 to $30.00 and set an “outperform” rating for the company in a research report on Wednesday, April 5th. Scotiabank reiterated a “sector perform” rating on shares of Livent in a research report on Wednesday, February 15th. Deutsche Bank Aktiengesellschaft lifted their price objective on Livent from $23.00 to $25.00 and gave the company a “hold” rating in a research report on Thursday, April 20th. Mizuho cut their price objective on Livent from $30.00 to $29.00 in a research report on Thursday, May 4th. Finally, CICC Research upgraded Livent from a “market perform” rating to an “outperform” rating in a research report on Thursday, May 4th. Five analysts have rated the stock with a hold rating and six have issued a buy rating to the company. Based on data from MarketBeat.com, Livent has a consensus rating of “Moderate Buy” and an average price target of $29.43.

Livent Profile

(Get Rating)

Livent Corp. engages in the production of performance lithium compounds. Its products include battery-grade lithium hydroxide, butyllithium, and purity lithium metal which are used in various performance applications. It operates through the following geographical segments: North America, Europe, Middle East, and Africa, Latin America, and Asia Pacific.